JP2025108645A5 - - Google Patents
Info
- Publication number
- JP2025108645A5 JP2025108645A5 JP2025069088A JP2025069088A JP2025108645A5 JP 2025108645 A5 JP2025108645 A5 JP 2025108645A5 JP 2025069088 A JP2025069088 A JP 2025069088A JP 2025069088 A JP2025069088 A JP 2025069088A JP 2025108645 A5 JP2025108645 A5 JP 2025108645A5
- Authority
- JP
- Japan
- Prior art keywords
- hsv
- infection
- immunogenic fragment
- rna encoding
- glycoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762546648P | 2017-08-17 | 2017-08-17 | |
| US62/546,648 | 2017-08-17 | ||
| US201862701019P | 2018-07-20 | 2018-07-20 | |
| US62/701,019 | 2018-07-20 | ||
| JP2020509054A JP7386535B2 (ja) | 2017-08-17 | 2018-08-17 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
| PCT/IB2018/056210 WO2019035066A1 (en) | 2017-08-17 | 2018-08-17 | MODIFIED MHRNA VACCINES ENCODING HERPES SIMPLEX VIRUS GLYCOPROTEINS AND USES THEREOF |
| JP2023138084A JP7674760B2 (ja) | 2017-08-17 | 2023-08-28 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023138084A Division JP7674760B2 (ja) | 2017-08-17 | 2023-08-28 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025108645A JP2025108645A (ja) | 2025-07-23 |
| JP2025108645A5 true JP2025108645A5 (https=) | 2026-02-26 |
Family
ID=65362983
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020509054A Active JP7386535B2 (ja) | 2017-08-17 | 2018-08-17 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
| JP2023138084A Active JP7674760B2 (ja) | 2017-08-17 | 2023-08-28 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
| JP2025069088A Pending JP2025108645A (ja) | 2017-08-17 | 2025-04-18 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020509054A Active JP7386535B2 (ja) | 2017-08-17 | 2018-08-17 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
| JP2023138084A Active JP7674760B2 (ja) | 2017-08-17 | 2023-08-28 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11141478B2 (https=) |
| EP (2) | EP4242223A3 (https=) |
| JP (3) | JP7386535B2 (https=) |
| CN (2) | CN111246854A (https=) |
| AU (2) | AU2018316811B2 (https=) |
| CA (1) | CA3073161A1 (https=) |
| WO (1) | WO2019035066A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA49463A (fr) * | 2017-04-26 | 2021-05-05 | Modernatx Inc | Vaccin contre le virus de l'herpès simplex |
| CN111246854A (zh) | 2017-08-17 | 2020-06-05 | 宾夕法尼亚大学理事会 | 编码单纯疱疹病毒糖蛋白的修饰mrna疫苗及其用途 |
| BR112021018039A2 (pt) * | 2019-03-12 | 2021-11-23 | BioNTech SE | Rna terapêutico para câncer de próstata |
| CN111568856B (zh) * | 2020-06-24 | 2021-07-06 | 珠海舒桐医疗科技有限公司 | 一种阴道凝胶制剂及其制备方法 |
| EP4171629A1 (en) * | 2020-06-29 | 2023-05-03 | GlaxoSmithKline Biologicals S.A. | Adjuvants |
| US12419948B2 (en) | 2020-08-31 | 2025-09-23 | The Broad Institute, Inc. | Immunogenic compositions and use thereof |
| EP4225360A1 (en) | 2020-10-08 | 2023-08-16 | Virothera Limited | Vaccine compositions |
| EP4032546A1 (en) * | 2021-01-20 | 2022-07-27 | GlaxoSmithKline Biologicals S.A. | Therapeutic viral vaccine |
| EP4032547A1 (en) * | 2021-01-20 | 2022-07-27 | GlaxoSmithKline Biologicals S.A. | Hsv1 fce derived fragements for the treatment of hsv |
| WO2022165313A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| JP2024512394A (ja) | 2021-03-11 | 2024-03-19 | レッドバイオテック・アーゲー | Ｈｓｖを処置するためのワクチン組成物及び方法 |
| CN118217388A (zh) * | 2022-12-19 | 2024-06-21 | 南京奥罗生物科技有限公司 | 单纯疱疹病毒疫苗及其应用 |
| EP4654996A1 (en) * | 2023-01-27 | 2025-12-03 | BioNTech SE | Pharmaceutical compositions for delivery of herpes simplex virus glycoprotein c, glycoprotein d, and glycoprotein e antigens and related methods |
| WO2024163918A1 (en) * | 2023-02-02 | 2024-08-08 | University Of Houston System | Mrna vaccine for herpes simplex virus |
| WO2024249967A1 (en) * | 2023-06-02 | 2024-12-05 | The Trustees Of The University Of Pennsylvania | Rna vaccines encoding herpes simplex virus glycoproteins and uses thereof |
| WO2025030165A1 (en) * | 2023-08-03 | 2025-02-06 | BioNTech SE | Pharmaceutical compositions for delivery of herpes simplex virus antigens and related methods |
| IL326358A (en) | 2023-08-03 | 2026-04-01 | Univ Pennsylvania | RNA compositions encoding herpes simplex virus glycoprotein E and/or glycoprotein I antigens and their uses |
| CN121843710A (zh) | 2023-08-03 | 2026-04-10 | 宾夕法尼亚大学理事会 | 编码单纯疱疹病毒糖蛋白b抗原的rna组合物及其用途 |
| CN121772938A (zh) * | 2023-08-03 | 2026-03-31 | 百欧恩泰欧洲股份公司 | 用于递送单纯疱疹病毒抗原的药物组合物及相关方法 |
| WO2025072383A1 (en) | 2023-09-25 | 2025-04-03 | The Broad Institute, Inc. | Viral open reading frames, uses thereof, and methods of detecting the same |
| WO2025097055A2 (en) | 2023-11-02 | 2025-05-08 | The Broad Institute, Inc. | Compositions and methods of use of t cells in immunotherapy |
| WO2025109008A1 (en) | 2023-11-20 | 2025-05-30 | Redbiotec Ag | Novel vaccine compositions and methods for treating hsv |
| WO2025129158A1 (en) | 2023-12-15 | 2025-06-19 | The Broad Institute, Inc. | Engineered arc delivery vesicles and uses thereof |
| WO2025175124A1 (en) * | 2024-02-15 | 2025-08-21 | Albert Einstein College Of Medicine | Recombinant herpes simplex virus glycoprotein b for treatment and prevention of herpes simplex virus infections |
| WO2025212831A1 (en) * | 2024-04-03 | 2025-10-09 | The Trustees Of The University Of Pennsylvania | Methods of inducing an anti-hsv b-cell immune response |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995026204A1 (en) | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
| EP3611266B1 (en) | 2005-08-23 | 2022-11-09 | The Trustees of the University of Pennsylvania | Rna containing modified nucleosides and methods of use thereof |
| EP2521786B1 (en) | 2006-07-20 | 2015-06-24 | Vical Incorporated | Compositions for vaccinating against hsv-2 |
| US20130028925A1 (en) | 2006-12-28 | 2013-01-31 | Harvey Friedman | Herpes simplex virus combined subunit vaccines and methods of use thereof |
| WO2008085486A1 (en) * | 2006-12-28 | 2008-07-17 | The Trustees Of The University Of Pennsylvania | Herpes simplex virus combined subunit vaccines and methods of use thereof |
| EP3756684A1 (en) * | 2009-05-22 | 2020-12-30 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| CA2816925C (en) | 2009-11-04 | 2023-01-10 | The University Of British Columbia | Nucleic acid-containing lipid particles and related methods |
| US9770463B2 (en) * | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
| US9192661B2 (en) * | 2010-07-06 | 2015-11-24 | Novartis Ag | Delivery of self-replicating RNA using biodegradable polymer particles |
| WO2012016184A2 (en) | 2010-07-30 | 2012-02-02 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for delivery of active agents |
| KR102136433B1 (ko) * | 2012-05-16 | 2020-07-22 | 이뮨 디자인 코포레이션 | Hsv-2 백신 |
| AU2014362234B2 (en) * | 2013-12-11 | 2019-09-12 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines |
| PE20170261A1 (es) * | 2014-05-13 | 2017-04-12 | Univ Pennsylvania | Composiciones que comprenden virus adenoasociado (aav) que expresa constructos de anticuerpos duales y sus usos |
| WO2016049705A1 (en) * | 2014-10-01 | 2016-04-07 | Admedus Vaccines Pty Ltd | Therapeutic compositions and methods for inducing an immune response to herpes simplex virus type 2 (hsv-2) |
| US20180303925A1 (en) | 2015-04-27 | 2018-10-25 | The Trustees Of The University Of Pennsylvania | Nucleoside-Modified RNA For Inducing an Adaptive Immune Response |
| US10758694B2 (en) | 2015-07-09 | 2020-09-01 | Hoyt Medical LLC | Systems and methods for treating an airway using a tapered adapter device |
| AU2016342049B2 (en) | 2015-10-22 | 2023-05-18 | Modernatx, Inc. | Herpes simplex virus vaccine |
| US20180289792A1 (en) * | 2015-10-22 | 2018-10-11 | ModernaTX. Inc. | Sexually transmitted disease vaccines |
| BR112019008481A2 (pt) * | 2016-10-26 | 2020-03-03 | Curevac Ag | Vacinas de mrna de nanopartículas lipídicas |
| MA49463A (fr) | 2017-04-26 | 2021-05-05 | Modernatx Inc | Vaccin contre le virus de l'herpès simplex |
| CN111246854A (zh) | 2017-08-17 | 2020-06-05 | 宾夕法尼亚大学理事会 | 编码单纯疱疹病毒糖蛋白的修饰mrna疫苗及其用途 |
-
2018
- 2018-08-17 CN CN201880068068.XA patent/CN111246854A/zh active Pending
- 2018-08-17 CA CA3073161A patent/CA3073161A1/en active Pending
- 2018-08-17 CN CN202410526392.9A patent/CN118370812A/zh active Pending
- 2018-08-17 EP EP23169155.1A patent/EP4242223A3/en active Pending
- 2018-08-17 JP JP2020509054A patent/JP7386535B2/ja active Active
- 2018-08-17 EP EP18846061.2A patent/EP3668520A4/en active Pending
- 2018-08-17 US US16/640,008 patent/US11141478B2/en active Active
- 2018-08-17 WO PCT/IB2018/056210 patent/WO2019035066A1/en not_active Ceased
- 2018-08-17 AU AU2018316811A patent/AU2018316811B2/en active Active
-
2021
- 2021-06-17 US US17/349,929 patent/US11793872B2/en active Active
-
2023
- 2023-08-28 JP JP2023138084A patent/JP7674760B2/ja active Active
- 2023-09-19 US US18/470,325 patent/US20240024463A1/en active Pending
- 2023-10-13 AU AU2023248194A patent/AU2023248194A1/en active Pending
-
2025
- 2025-04-18 JP JP2025069088A patent/JP2025108645A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025108645A5 (https=) | ||
| Krishnan et al. | Developments in vaccination for herpes simplex virus | |
| JP2023153423A5 (https=) | ||
| Dupuy et al. | Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes | |
| JP2020531465A5 (https=) | ||
| Aurelian | Herpes simplex virus type 2 vaccines: new ground for optimism? | |
| Jean-Pierre et al. | Main targets of interest for the development of a prophylactic or therapeutic Epstein-Barr virus vaccine | |
| Alami Chentoufi et al. | Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown | |
| TW200400046A (en) | Viral antigens | |
| CA2674051A1 (en) | Herpes simplex virus combined subunit vaccines and methods of use thereof | |
| JP2004535798A (ja) | ヘルペスウイルスを用いた癌処置のための組成物および方法 | |
| EP1556513B1 (en) | Compositions and methods for treating human papillomavirus-mediated disease | |
| US20190100561A1 (en) | Herpes simplex virus vaccine | |
| Wachsman et al. | A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs | |
| Bolhassani et al. | Different spectra of therapeutic vaccine development against HPV infections | |
| Higgins et al. | Plasmid DNA—Expressed Secreted and Nonsecreted Forms of Herpes Simplex Virus Glycoprotein D2 Induce Different Types of Immune Responses | |
| Bright et al. | The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP27 | |
| Yan et al. | CCL19 and CCL28 assist herpes simplex virus 2 glycoprotein D to induce protective systemic immunity against genital viral challenge | |
| US20240156951A1 (en) | Vaccine compositions and methods for treating hsv | |
| CN114681602B (zh) | 一种双价人乳头瘤病毒疫苗 | |
| JP2014534262A5 (https=) | ||
| Devadasan et al. | HPV vaccines–A game changer for preventing HPV-related cancers | |
| Wang et al. | Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice | |
| KR20070050465A (ko) | 경구 투여 백신 | |
| Ramachandran et al. | Potential prophylactic and therapeutic vaccines for HSV infections |